Anxiety & Stress Disorders

Incannex Healthcare shared positive data from its phase 2 clinical trial of PSX-001, a psilocybin-assisted psychotherapy treatment for generalized anxiety disorder.

Youth with neurodevelopmental disorders face significant suicide risks.

Exploring the impact of fermented foods like sauerkraut on social anxiety, revealing surprising insights and practical solutions for mental health.

Discover the transformative power of pausing and resetting through meditation and breathing techniques for enhanced well-being and resilience.

Seaport Therapeutics initiates a pivotal study for GlyphAllo, a potential breakthrough treatment for major depressive disorder, with or without anxious stress.

Marc Potenza, PhD, MD, explores the impact of online social activity on ADHD symptoms in adolescents, revealing significant gender differences in brain development and attention.

Augmented reality can transform psychiatric treatment, enhancing exposure therapy for trauma and anxiety by simulating real-world environments and interactions.

In this CME article, learn more about the essential role of MAOIs in treating resistant depression and anxiety.

Uncertainty fuels anxiety, yet knowing outcomes—even grim ones—can bring relief.

Effective diagnosis and treatment of comorbid disorders in patients with bipolar enhance care and lead to more optimal mental health outcomes.

What is the hidden mental health struggles of affluent youth? In this Tales From the Clinic article, we reveal how wealth can contribute to anxiety, depression, and substance misuse.

Check out the pipeline updates from April!

In this CME article, explore the complexities of Parkinson disease, focusing on neuropsychiatric symptoms, their prevalence, and effective treatment strategies for improved patient care.

Cybin partners with Osmind to enhance mental health treatment access, focusing on innovative therapies for depression and anxiety disorders.

The first patient has been dosed in MindMed’s phase 3 Emerge study evaluating the efficacy of MM120 ODT.

A pioneer in cognitive behavior therapy shares his thoughts on a 50-year-long career.

New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.

Are TV shows educating the public about psychiatric medications?

What is the difference between worry and anxiety disorders?

Epidemiological data show that rates of anxiety, depression, self-injurious behaviors, and suicidality increased for Gen Z in significantly higher numbers than previous generations.

Learn more about the latest research on the impact the endocrine system has on major depressive disorder.

In mice models, opioid delta-receptor agonists showed promise in helping to relieve abdominal pain and regulate bowel movements. Is targeting the brain the best path forward for IBS treatment?

Meditation using immersive virtual reality devices can help alleviate symptoms of major depressive disorder and generalized anxiety disorder.

How does affluence impact mental health outcomes?

Clinicians should consider rTMS as an intervention to alleviate OCD symptoms, especially in those who have failed other treatments or those with comorbid depression.